Feline Aβ40 antibody and antigen (recombinant protein)
Diagnostic anti-Feline Aβ40 antibodies pairs and antigen for animal health (animal Cat/Feline Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-AB40-Ag01 | Recombinant Feline Aβ40 protein | 3090 |
GMP-FEL-AB40-Ab01 | Anti-Feline Aβ40 mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-AB40-Ab02 | Anti-Feline Aβ40 mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-AB40-Ab03 | Anti-Feline Aβ40 human monoclonal antibody (mAb) | 1953 |
GMP-FEL-AB40-Ab04 | Anti-Feline Aβ40 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-AB40-Ag01 |
Product Name | Recombinant Feline Aβ40 protein |
Target/Biomarker | Feline beta-amyloid 40 (AIV-A H7N7 subtype) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline beta-amyloid 40 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A H7N7 subtype level test of animal Cat/Feline with Alzheimer Disease(AD). |
Tag | His |
Products description | Recombinant Feline Aβ40 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-AB40-Ab01, GMP-FEL-AB40-Ab02 |
Product Name | Anti-Feline Aβ40 mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline beta-amyloid 40 (AIV-A H7N7 subtype) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline beta-amyloid 40 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N7 subtype antibodies in AIV-A H7N7 subtype level test of animal Cat/Feline with Alzheimer Disease(AD). |
Tag | mFc |
Products description | Anti-Feline Aβ40 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N7 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-AB40-Ab03, GMP-FEL-AB40-Ab04 |
Product Name | Anti-Feline Aβ40 human monoclonal antibody (mAb) |
Target/Biomarker | Feline beta-amyloid 40 (AIV-A H7N7 subtype) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Feline beta-amyloid 40 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N7 subtype antibodies in AIV-A H7N7 subtype level test of animal Cat/Feline with Alzheimer Disease(AD). |
Tag | hFc |
Products description | Anti-Feline Aβ40 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N7 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Feline Amyloid-beta 40 (Aβ40) stands as a pivotal molecule in feline neuroscience, assuming a central role in our understanding of neurodegenerative conditions affecting our cherished feline companions. Comprising 40 amino acids, Aβ40 is a fragment of the amyloid precursor protein (APP) and represents a critical component in the formation of amyloid plaques within the feline brain. These plaques, predominantly composed of Aβ40, symbolize cognitive decline in cats, most notably in cases of feline cognitive dysfunction syndrome (FCDS), which shares similarities with Alzheimer's disease in humans. The genesis of Aβ40 involves proteolytic cleavage of APP, a process mediated by β-secretase and γ-secretase enzymes. In cats afflicted by FCDS, an imbalance in Aβ40 metabolism and clearance leads to its aggregation, culminating in the accumulation of amyloid plaques. These plaques disrupt normal neural function, contributing substantially to the cognitive deficits and memory impairments observed in affected cats. The implications of Aβ40 aggregation extend beyond cognitive deficits. Aβ40 aggregates can trigger neuroinflammatory responses, oxidative stress, and synaptic dysfunction, collectively exacerbating the neurodegenerative processes occurring in cats suffering from FCDS.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.